Genetic basis of intellectual disability

Annual Review of Medicine

Volumn 64, Issue , 2013, Pages 441-450

  Ellison, Jay W ^a   Rosenfeld, Jill A ^a   Shaffer, Lisa G ^a  

^a PERKINELMER INC   (United States)

Author keywords

chromosome disorder; microarray analysis; neurodevelopmental phenotypes; next generation sequencing

Indexed keywords

AUTISM; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; COPY NUMBER VARIATION; CYTOGENETICS; FRAGILE X SYNDROME; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INHERITANCE; INTELLECTUAL IMPAIRMENT; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

DNA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTELLECTUAL DISABILITY; MUTATION; PHENOTYPE;

EID: 84873027175     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-042711-140053     Document Type: Review

References (58)

1. Salvador-Carulla L, Bertelli M. 2008. "Mental retardation" or "intellectual disability": time for a conceptual change. Psychopathology 41:10-16
2. World Health Organization: Regional Office for Europe. 2010. Definition: intellectual disability. http://www.euro.who.int/en/what-we-do/health-topics/ noncommunicable-diseases/mental-health/news/news/2010/15/childrens-right-to- family-life/definition-intellectual-disability
3. American Association on Intellectual and DevelopmentalDisabilities (AAIDD). 2010. Overview of intellectual disability: definition, classification, and systems of support. Presented at AAIDD Annu.Meet., Providence, RI, June 8-11. http://www.aaidd.org/media/PDFs/CoreSlide.pdf
4. Leonard H, Wen X. 2002. The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment. Retard. Dev. Disabil. Res. Rev. 8:117-34
5. Centers for Disease Control and Prevention. 2004. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003. Morb.Mortal.Wkly. Rep. 53:57-59
6. Rauch A, Hoyer J, Guth S, et al. 2006. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am. J. Med. Genet. Part A 140:2063-74
7. Cooper GM, Coe BP, Girirajan S, et al. 2011. A copy number variation morbidity map of developmental delay. Nat. Genet. 43:838-46
8. Kaminsky EB, Kaul V, Paschall J, et al. 2011. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet. Med. 13:777-84
9. Vissers LE, de Vries BB, Veltman JA. 2010. Genomic microarrays in mental retardation: from copy number variation to gene, from research to diagnosis. J. Med. Genet. 47:289-97
10. Morrow EM. 2010. Genomic copy number variation in disorders of cognitive development. J. Am. Acad. Child Adolesc. Psychiatry 49:1091-104
11. Zahir F, Friedman JM. 2007. The impact of array genomic hybridization on mental retardation research: a review of current technologies and their clinical utility. Clin. Genet. 72:271-87
12. Miller DT, Adam MP, Aradhya S, et al. 2010. Consensus statement: Chromosomal microarray is a firsttier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 86:749-64
13. Hochstenbach R, van Binsbergen E, Engelen J, et al. 2009. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36, 325 patients with idiopathic developmental delay in the Netherlands. Eur. J. Med. Genet. 52:161-69
14. Lugtenberg D, Veltman JA, van Bokhoven H. 2007. High-resolution genomic microarrays for X-linked mental retardation. Genet. Med. 9:560-65
15. TalkowskiME, Mullegama SV, Rosenfeld JA, et al. 2011. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am. J. Hum. Genet. 89:551-63
16. Durand CM, Betancur C, Boeckers TM, et al. 2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39:25-27
17. Koolen DA, Kramer JM, Neveling K, et al. 2012. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat. Genet. 44:639-41
18. Ballif BC, Rosenfeld JA, Traylor R, et al. 2012. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44. Hum. Genet. 131:145-56
19. ZollinoM, Orteschi D, MurdoloM, et al. 2012. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nat. Genet. 44:636-38
20. Pieretti M, Zhang FP, Fu YH, et al. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-22
21. Fu YH, KuhlDP, Pizzuti A, et al. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-58
22. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-14
23. Coffee B, Keith K, Albizua I, et al. 2009. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am. J. Hum. Genet. 85:503-14
24. Christodoulou J, Ho G. 2001 (updated 2009). MECP2-related disorders. In GeneReviews, ed. RA Pagon, TD Bird, CR Dolan, et al., 1993-. Seattle: Univ. Washington. http://www.ncbi.nlm.nih.gov/books/NBK1497/
25. Ropers HH, Hamel BC. 2005. X-linked mental retardation. Nat. Rev. Genet. 6:46-57
26. Ropers HH. 2010. Genetics of early onset cognitive impairment. Annu. Rev. Genomics Hum. Genet. 11:161-87
27. Tarpey PS, Smith R, Pleasance E, et al. 2009. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat. Genet. 41:535-43
28. Lubs HA, Stevenson RE, Schwartz CE. 2012. Fragile X and X-linked intellectual disability: four decades of discovery. Am. J. Hum. Genet. 90:579-90
29. Vissers LE, de Ligt J, Gilissen C, et al. 2010. A de novo paradigm for mental retardation. Nat. Genet. 42:1109-12
30. Willemsen MH, Vissers LEL, Willemsen MAAP, et al. 2012. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J. Med. Genet. 49:179-83
31. Weedon MN, Hastings R, Caswell R, et al. 2011. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 89:308-12
32. Need AC, Shashi V, Hitomi Y, et al. 2012. Clinical application of exome sequencing in undiagnosed genetic conditions. J. Med. Genet. 49:353-61
33. Kuss AW, Garshasbi M, Kahrizi K, et al. 2011. Autosomal recessive mental retardation: Homozygosity mapping identifies 27 single linkage intervals, at least 14 novel loci and several mutation hotspots. Hum. Genet. 129:141-48
34. Najmabadi H, Hu H, Garshasbi M, et al. 2011. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478:57-63
35. Melom JE, Littleton JT. 2011. Synapse development in health and disease. Curr. Opin. Genet. Dev. 21:256-61
36. Guilmatre A, Dubourg C, Mosca AL, et al. 2009. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 66:947-56
37. Hamdan FF, Gauthier J, Araki Y, et al. 2011. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am. J. Hum. Genet. 88:306-16
38. Bolduc FV, Tully T. 2009. Fruit flies and intellectual disability. Fly (Austin) 3:91-104
39. Hu H, Eggers K, Chen W, et al. 2011. ST3GAL3 mutations impair the development of higher cognitive functions. Am. J. Hum. Genet. 89:407-14
40. Thornton GK, Woods CG. 2009. Primary microcephaly: Do all roads lead to Rome? Trends Genet. 25:501-10
41. Kaufman L, Ayub M, Vincent JB. 2010. The genetic basis of non-syndromic intellectual disability: a review. J. Neurodev. Disord. 2:182-209
42. Bryson SE, Bradley EA, ThompsonA, et al. 2008. Prevalence of autism among adolescentswith intellectual disabilities. Can. J. Psychiatry 53:449-59
43. Fombonne E. 2003. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J. Autism Dev. Disord. 33:365-82
44. Mefford HC, Batshaw ML, Hoffman EP. 2012. Genomics, intellectual disability, and autism. N. Engl. J. Med. 366:733-43
45. Walsh T, McClellan JM, McCarthy SE, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:539-43
46. Malhotra D, Sebat J. 2012. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 148:1223-41
47. Zoghbi HY, Warren ST. 2010. Neurogenetics: advancing the "next-generation" of brain research. Neuron 68:165-73
48. Sebat J, Levy DL, McCarthy SE. 2009. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 25:528-35
49. Malhotra D, McCarthy S, Michaelson JJ, et al. 2011. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72:951-63
50. Mitchell KJ. 2007. The genetics of brain wiring: from molecule to mind. PLoS Biol. 5:e113
51. Penrose LS. 1938. A clinical and genetic study of 1280 cases of mental defect. London: H.M. Stationery Off. 159 pp.
52. Lupski JR. 2010. New mutations and intellectual function. Nat. Genet. 42:1036-38
53. Robinson PN. 2010. Whole-exome sequencing for finding de novo mutations in sporadic mental retardation. Genome Biol. 11:144
54. Huang K. 2011. De novo paradigm: the ultimate answer to the paradox in mental retardation? Clin. Genet. 79:427-28
55. Mitchell KJ. 2012. What is complex about complex disorders? Genome Biol. 13:237
56. Girirajan S, Rosenfeld JA, Cooper GM, et al. 2010. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat. Genet. 42:203-9
57. Schaaf CP, Sabo A, Sakai Y, et al. 2011. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum. Mol. Genet. 20:3366-75
58. Badano JL, Katsanis N. 2002. Beyond Mendel: an evolving view of human genetic disease transmission. Nat. Rev. Genet. 3:779-89